Clinical Trial: To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: A Research Study to Describe the Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS). An Assessment of Two Case Studies

Brief Summary: This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.

Detailed Summary:
Sponsor: Alexion Pharmaceuticals

Current Primary Outcome: Change in platelet count from baseline [ Time Frame: 26 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Alexion Pharmaceuticals

Dates:
Date Received: December 4, 2012
Date Started: May 2012
Date Completion:
Last Updated: December 21, 2012
Last Verified: February 2012